Rule 17a-12; Reporting Requirements for OTC Derivatives Dealers.

Forms and Documents

Document Name	Status
Form SEC 2430 Rule 17a-12; Reporting Requirements for OTC Derivatives Dealers. Form and Instruction	Modified
Supporting Statement 17a-12 (2).doc 2019 DGL FINAL.pdf Supporting Statement A	2019-02-05
30 day notice for Rule 17a-12.pdf Supplementary Document	2019-02-05
60 day notice for Rule 17a-12.pdf Supplementary Document	2019-02-05

IC Document Collections

IC ID	Document Title	Status
35256	Rule 17a-12; Reporting Requirements for OTC Derivatives Dealers. Form and Instruction	Modified
204890	Rule 17a-12 Professional Accountant Review Requirements	Modified

ICR Details

OMB Control No: 3235-0498	ICR Reference No: 201806-3235-014
Status: Active	Previous ICR Reference No: 201509-3235-001
Agency/Subagency: SEC	Agency Tracking No: TM-270-442
Title: Rule 17a-12; Reporting Requirements for OTC Derivatives Dealers.
Type of Information Collection: Extension without change of a currently approved collection	Common Form ICR:  No
Type of Review Request: Regular
OIRA Conclusion Action: Approved without change	Conclusion Date: 04/25/2019
	Date Received in OIRA: 02/05/2019
Terms of Clearance:

	Inventory as of this Action	Requested	Previously Approved
Expiration Date	04/30/2022	36 Months From Approved	04/30/2019
Responses	12	0	30
Time Burden (Hours)	1,080	0	900
Cost Burden (Dollars)	277,800	0	231,500

---

Abstract: Rule 17a-12 sets forth requirements for OTC derivatives dealers registered with the Commission to report financial and operational information to the Commission. Form X-17A-5IIB is the form used by OTC derivatives dealers to report this information.

---

Authorizing Statute(s): US Code: 15 USC 78a Name of Law: Securities Exchange Act of 1934
  

Citations for New Statutory Requirements: None

---

Associated Rulemaking Information
RIN:	Stage of Rulemaking:	Federal Register Citation:	Date:
	Not associated with rulemaking

---

Federal Register Notices & Comments
60-day Notice:	Federal Register Citation:	Citation Date:
	83 FR 42959	08/24/2018
30-day Notice:	Federal Register Citation:	Citation Date:
	83 FR 55209	11/02/2018
Did the Agency receive public comments on this ICR? No

---

Number of Information Collection (IC) in this ICR: 2

IC Title	Form No.	Form Name
Rule 17a-12; Reporting Requirements for OTC Derivatives Dealers.	SEC 2430	Form X-17A-5
Rule 17a-12 Professional Accountant Review Requirements

---

ICR Summary of Burden

	Total Approved	Previously Approved	Change Due to New Statute	Change Due to Agency Discretion	Change Due to Adjustment in Estimate	Change Due to Potential Violation of the PRA
Annual Number of Responses	12	30	0	0	-18	0
Annual Time Burden (Hours)	1,080	900	0	0	180	0
Annual Cost Burden (Dollars)	277,800	231,500	0	0	46,300	0

Burden increases because of Program Change due to Agency Discretion: No

Burden Increase Due to:

Burden decreases because of Program Change due to Agency Discretion: No

Burden Reduction Due to:

Short Statement: The number of firms registered with the Commission as OTC derivatives dealers has changed from four firms to three firms. The staff now expects that three more firms will register with the Commission as an OTC derivatives dealer within the next three years. Formerly, the staff estimated that one more firm would register as an OTC derivatives dealer. Therefore, the total number of respondents has changed from five to six. As a result, the total annual hour reporting burden and the annual industry-wide reporting cost have increased.

---

Annual Cost to Federal Government: $0

Does this IC contain surveys, censuses, or employ statistical methods? No

Does this ICR request any personally identifiable information (see OMB Circular No. A-130 for an explanation of this term)? Please consult with your agency's privacy program when making this determination.     No

Does this ICR include a form that requires a Privacy Act Statement (see 5 U.S.C. §552a(e)(3))? Please consult with your agency's privacy program when making this determination.     No

Is this ICR related to the Affordable Care Act [Pub. L. 111-148 & 111-152]? No

Is this ICR related to the Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]? No

Is this ICR related to the American Recovery and Reinvestment Act of 2009 (ARRA)? No

Is this ICR related to the Pandemic Response? Uncollected

---

Common Form ICR:  No

---

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).

The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:

(a) It is necessary for the proper performance of agency functions;

(b) It avoids unnecessary duplication;

(c) It reduces burden on small entities;

(d) It uses plain, coherent, and unambiguous language that is understandable to respondents;

(e) Its implementation will be consistent and compatible with current reporting and recordkeeping practices;

(f) It indicates the retention periods for recordkeeping requirements;

(g) It informs respondents of the information called for under 5 CFR 1320.8 (b)(3) about:

(i) Why the information is being collected;

(ii) Use of information;

(iii) Burden estimate;

(iv) Nature of response (voluntary, required for a benefit, or mandatory);

(v) Nature and extent of confidentiality; and

(vi) Need to display currently valid OMB control number;

(h) It was developed by an office that has planned and allocated resources for the efficient and effective management and use of the information to be collected.

(i) It uses effective and efficient statistical survey methodology (if applicable); and

(j) It makes appropriate use of information technology.

If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.

Certification Date: 02/05/2019

---